Abstract:BACKGROUND:Increasing evidences demonstrate that miRNAs contribute to development and progression of hepatocellular carcinoma (HCC). Underexpression of miR-1296 is recently reported to promote growth and metastasis of human cancers. However, the expression and role of miR-1296 in HCC remain unknown.METHODS:The levels of miR-1296 in HCC tissues and cells were detected by qRT-PCR. Immunoblotting and immunofluorescence were used for detection of epithelial-to-mesenchymal transition (EMT) progression in HCC cells. Transwell assays were performed to determine migration and invasion of HCC cells. A lung metastasis mouse model was used to evaluated metastasis of HCC in vivo. The putative targets of miR-1296 were disclosed by public databases and a dual-luciferase reporter assay.RESULTS:We found that the expression of miR-1296 was reduced in HCC tissues and cell lines, and it was associated with metastasis and recurrence of HCC. Notably, miR-1296 overexpression inhibited migration, invasion and EMT progress of HCCLM3 cells, while miR-1296 loss facilitated these biological behaviors of Hep3B cells in vitro and in vivo. In addition, miR-1296 inversely regulated SRPK1 abundance by directly binding to its 3'-UTR, which subsequently resulted in suppression of p-AKT. Either SRPK1 re-expression or PI3K/AKT pathway activation, at least partially, abolished the effects of miR-1296 on migration, invasion and EMT progress of HCC cells. Furthermore, miR-1296 and SRPK1 expression were markedly correlated with adverse clinical features and poor prognosis of HCC patients. We showed that hypoxia was responsible for the underexpression of miR-1296 in HCC. And the promoting effects of hypoxia on metastasis and EMT of HCC cells were reversed by miR-1296.CONCLUSIONS:Underexpression of miR-1296 potentially serves as a prognostic biomarker in HCC. Hypoxia-induced miR-1296 loss promotes metastasis and EMT of HCC cells probably by targeting SRPK1/AKT pathway.

MicroRNA-1271-5p inhibits cell proliferation and enhances radiosensitivity by targeting CDK1 in hepatocellular carcinoma.

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27.

MiR-126 Enhances Cisplatin Chemosensitivity in Hepatocellular Carcinoma Cells by Targeting IRS1

Mir-1299 Suppresses Cell Proliferation of Hepatocellular Carcinoma (hcc) by Targeting Cdk6

MicroRNA-1284 enhances radio-sensitivity in hepatocellular carcinoma cells by regulating SP 1

MicroRNA-1271 Functions As a Metastasis and Epithelial-Mesenchymal Transition Inhibitor in Human HCC by Targeting the PTP4A1/c-Src Axis.

MiR-29a Suppresses Cell Proliferation by Targeting SIRT1 in Hepatocellular Carcinoma

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

MicroRNA-627-5p inhibits the proliferation of hepatocellular carcinoma cells by targeting BCL3 transcription coactivator.

miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8

MicroRNA-203 increase cell radiosensitivity via directly targeting Bmi-1 in hepatocellular carcinoma.

MicroRNA-126 Inhibits Tumor Proliferation and Angiogenesis of Hepatocellular Carcinoma by Down-Regulating EGFL7 Expression.

MicroRNA-377-3p Promotes Cell Proliferation and Inhibits Cell Cycle Arrest and Cell Apoptosis in Hepatocellular Carcinoma by Affecting EGR1-mediated P53 Activation.

MicroRNA‐127‐5p Targets the Biliverdin Reductase B/nuclear Factor‐κb Pathway to Suppress Cell Growth in Hepatocellular Carcinoma Cells

Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.

MicroRNA-1296 Inhibits Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting SRPK1-mediated PI3K/AKT Pathway

MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1

miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3

MicroRNA-139 Inhibits Hepatocellular Carcinoma Cell Growth Through Down-Regulating Karyopherin Alpha 2